Balaxi [BALAXI] vs Zota Health Care [ZOTA] Detailed Stock Comparison

Balaxi Pharmaceuticals Ltd.

NSE
Loading...

Zota Health Care Limited

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Balaxi Pharmaceuticals Ltd. wins in 14 metrics, Zota Health Care Limited wins in 4 metrics, with 0 ties. Balaxi Pharmaceuticals Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Balaxi Pharmaceuticals Ltd. Zota Health Care Limited Better
P/E Ratio (TTM) 15.75 -62.53 Balaxi Pharmaceuticals Ltd.
Price-to-Book Ratio 0.59 12.61 Balaxi Pharmaceuticals Ltd.
Debt-to-Equity Ratio 23.75 56.90 Balaxi Pharmaceuticals Ltd.
PEG Ratio -0.17 -0.59 Balaxi Pharmaceuticals Ltd.
EV/EBITDA 7.58 -126.59 Balaxi Pharmaceuticals Ltd.
Profit Margin (TTM) 3.42% -15.37% Balaxi Pharmaceuticals Ltd.
Operating Margin (TTM) 3.49% -15.88% Balaxi Pharmaceuticals Ltd.
EBITDA Margin (TTM) 3.49% N/A N/A
Return on Equity 10.82% -24.83% Balaxi Pharmaceuticals Ltd.
Return on Assets (TTM) 8.08% -12.84% Balaxi Pharmaceuticals Ltd.
Free Cash Flow (TTM) $-567.67M $-959.42M Balaxi Pharmaceuticals Ltd.
Dividend Yield N/A 0.07% N/A
1-Year Return -56.05% 27.17% Zota Health Care Limited
Price-to-Sales Ratio (TTM) 0.54 8.34 Balaxi Pharmaceuticals Ltd.
Enterprise Value $1.55B $45.66B Zota Health Care Limited
EV/Revenue Ratio 0.56 9.66 Balaxi Pharmaceuticals Ltd.
Gross Profit Margin (TTM) 42.47% 60.28% Zota Health Care Limited
Revenue per Share (TTM) $51 $157 Zota Health Care Limited
Earnings per Share (Diluted) $1.71 $-23.94 Balaxi Pharmaceuticals Ltd.
Beta (Stock Volatility) 0.16 0.36 Balaxi Pharmaceuticals Ltd.

Balaxi Pharmaceuticals Ltd. vs Zota Health Care Limited Stock Performance Analysis

Loading Price Chart...

BALAXI
ZOTA

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Balaxi Pharmaceuticals Ltd.4.11%-2.90%-8.08%34.63%-18.08%-15.91%
Zota Health Care Limited1.75%3.68%3.22%14.06%-26.10%-17.99%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Balaxi Pharmaceuticals Ltd.-56.05%-78.64%-80.93%376.04%661.67%661.67%
Zota Health Care Limited27.17%243.00%632.12%1,248.00%1,248.00%1,248.00%

Performance & Financial Health Analysis: Balaxi Pharmaceuticals Ltd. vs Zota Health Care Limited

MetricBALAXIZOTA
Market Information
Market Cap i₹1.49B₹39.41B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i80,09856,411
90 Day Avg. Volume i166,61153,265
Last Close₹23.79₹1,246.70
52 Week Range₹15.20 - ₹54.70₹917.20 - ₹1,740.00
% from 52W High-56.51%-28.35%
All-Time High₹216.04 (Oct 12, 2020)₹1,740.00 (Nov 21, 2025)
% from All-Time High-88.99%-28.35%
Growth Metrics
Quarterly Revenue Growth-0.01%0.98%
Quarterly Earnings Growth-0.94%1.12%
Financial Health
Profit Margin (TTM) i0.03%-0.15%
Operating Margin (TTM) i0.03%-0.16%
Return on Equity (TTM) i0.11%-0.25%
Debt to Equity (MRQ) i23.7556.90
Cash & Liquidity
Book Value per Share (MRQ)₹45.56₹103.04
Cash per Share (MRQ)₹7.64₹1.87
Operating Cash Flow (TTM) i₹-196,221,000₹-1,007,999,000
Levered Free Cash Flow (TTM) i₹250.70M₹-563,984,000
Dividends
Last 12-Month Dividend Yield iN/A0.07%
Last 12-Month Dividend i₹0.00₹1.00

Valuation & Enterprise Metrics Analysis: Balaxi Pharmaceuticals Ltd. vs Zota Health Care Limited

MetricBALAXI (Apr 26, 2026)ZOTA (Apr 22, 2026)
Price Ratios
P/E Ratio (TTM) i15.75-62.53
Forward P/E iN/AN/A
PEG Ratio i-0.17-0.59
Price to Sales (TTM) i0.548.34
Price to Book (MRQ) i0.5912.61
Market Capitalization
Market Capitalization i₹1.49B₹39.41B
Enterprise Value i₹1.55B₹45.66B
Enterprise Value Metrics
Enterprise to Revenue i0.569.66
Enterprise to EBITDA i7.58-126.59
Risk & Other Metrics
Beta i0.160.36
Book Value per Share (MRQ) i₹45.56₹103.04

Financial Statements Comparison: Balaxi Pharmaceuticals Ltd. vs Zota Health Care Limited

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricBALAXI (2025)ZOTA (2025)
Revenue/Sales i2.93B2.93B
Cost of Goods Sold i1.66B1.44B
COGS % of Revenue i56.6%49.0%
Gross Profit i1.27B1.49B
Gross Margin i43.4%51.0%
Research & Development iN/AN/A
Operating Income (EBIT) i363.99M-480.90M
Operating Margin i12.4%-16.4%
EBITDA i334.99M-42.20M
EBITDA Margin i11.5%-1.4%
Pre-Tax Income i286.70M-576.44M
Pre-Tax Income % of Revenue i9.8%-19.7%
Income Tax i35.99M-9.06M
Income Tax % of Revenue i1.2%-0.3%
Net Income (Profit) i250.70M-567.39M
Profit Margin i8.6%-19.4%

Balance Sheet & Liquidity Metrics

MetricBALAXI (2025)ZOTA (2025)
Cash & Equivalents i394.00M21.32M
Total Current Assets i2.43B1.84B
Total Current Assets % of Revenue i83.0%62.9%
Total Current Liabilities i545.32M1.01B
Total Current Liabilities % of Revenue i18.6%34.3%
Long-Term Debt i230.46M1.08B
Long-Term Debt % of Revenue i7.9%36.7%
Total Shareholders Equity i2.32B2.27B
Retained Earnings i1.63B-191.89M
Retained Earnings % of Revenue i55.9%-6.5%
Property, Plant & Equipment i55.44M65.25M

Cash Flow Statement Comparison

MetricBALAXI (2025)ZOTA (2025)
Operating Cash Flow i-196.22M-1.01B
Operating Cash Flow % of Revenue i-6.7%-34.4%
Capital Expenditures i-211.19M-459.67M
Free Cash Flow i-567.67M-959.42M
FCF Margin i-19.4%-32.7%
Debt Repayment iN/A-140.67M
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricBALAXIZOTA
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i55.21M30.33M
Float Shares i8.81M15.02M
% Held by Insiders iN/A0.00%
% Held by Institutions iN/A1.16%
% Held by Public iN/A98.84%

Dividend Analysis & Yield Comparison: Balaxi Pharmaceuticals Ltd. vs Zota Health Care Limited

MetricBALAXIZOTA
Last 12-Month Dividend i₹0.00₹1.00
Last 12-Month Dividend Yield iN/A0.07%
3-Year Avg Annual Dividend i₹0.01₹1.00
3-Year Avg Dividend Yield i0.03%0.16%
3-Year Total Dividends i₹0.02₹3.00
Ex-Dividend DateJul 01, 2022Sep 22, 2025